```html

Seasonal Flu (Influenza) – Comprehensive Medical Guide

Overview

Influenza, commonly called the seasonal flu, is an acute respiratory infection caused by influenza viruses that circulate each year. There are three main types that affect humans—**influenza A, B, and C**—but seasonal epidemics are driven primarily by influenza A (subtypes H1N1 and H3N2) and influenza B (lineages Victoria and Yamagata).

The disease spreads worldwide in annual waves, typically peaking during the fall and winter months in temper­ate climates. According to the U.S. Centers for Disease Control and Prevention (CDC), seasonal flu infects 5–20% of the global population each year, resulting in an estimated 3–5 million cases of severe illness and 290 000–650 000 deaths worldwide.

While anyone can catch the flu, certain groups—young children, older adults, pregnant people, and individuals with chronic medical conditions—are at higher risk for severe disease.

Symptoms

Flu symptoms usually appear abruptly, often within 1‑4 days after exposure. The classic presentation includes a combination of systemic and respiratory signs:

• Fever or chills – temperature ≥ 38 °C (100.4 °F) in about 70% of adults; children may have higher fevers.
• Dry, persistent cough – may become harsh and last up to two weeks.
• Sore throat – often accompanies the cough.
• Runny or stuffy nose – nasal congestion can be severe.
• Muscle or body aches – especially in the back, legs, and arms.
• Headache – can be throbbing and generalized.
• Fatigue or weakness – may last for weeks after other symptoms improve.
• Gastrointestinal symptoms – nausea, vomiting, or diarrhea are more common in children.
• Chest discomfort – can feel like a pressure or tightness.

Symptoms usually last 5‑7 days, but cough and fatigue can linger for two weeks or longer. In high‑risk individuals, the flu can progress rapidly to severe pneumonia or organ failure.

Causes and Risk Factors

What Causes Seasonal Flu?

Influenza viruses are enveloped, single‑stranded RNA viruses that mutate frequently. Two processes drive their evolution:

• Antigenic drift – Small, continuous genetic changes that allow the virus to evade pre‑existing immunity, leading to yearly epidemics.
• Antigenic shift – Rare, abrupt reassortment of gene segments (mainly in influenza A) that can create a novel virus capable of causing a pandemic.

Transmission occurs mainly through respiratory droplets when an infected person coughs, sneezes, or talks, and via fomites when contaminated hands contact the nose or mouth.

Who Is at Higher Risk?

• Children < 5 years (especially < 2 years)
• Adults ≥ 65 years
• Pregnant people and those up to 2 weeks postpartum
• People with chronic lung (e.g., asthma, COPD), heart, kidney, or liver disease
• Individuals with immune‑compromising conditions (HIV/AIDS, cancer chemotherapy, organ transplant)
• Residents of long‑term care facilities
• Obesity (BMI ≥ 30 kg/m²) – associated with more severe outcomes
• People with neurologic or metabolic disorders (e.g., diabetes, sickle‑cell disease)

Diagnosis

Clinical judgment remains essential, but laboratory testing improves accuracy, guides antiviral therapy, and helps public‑health surveillance.

When to Test

• Patients who are hospitalized, have severe or worsening illness, or are at high risk for complications.
• Outpatients with a fever ≥ 38 °C and a cough or sore throat during flu season, especially if they present within 48 hours of symptom onset (when antivirals are most effective).

Testing Methods

1. Rapid Influenza Diagnostic Tests (RIDTs) – Detect viral antigens in <10‑15 minutes. Sensitivity ranges 50‑70%; a negative result does not rule out flu.
2. Molecular assays (RT‑PCR) – Highly sensitive (≥ 95%) and specific; considered the gold standard. Results available within 1‑2 hours in many labs.
3. Viral culture – Takes 3‑5 days; used mainly for research and surveillance.
4. Serology – Paired acute and convalescent sera; rarely used clinically because antibodies appear 7‑14 days after infection.

Treatment Options

Early treatment (within 48 hours of symptom onset) shortens illness by ~1‑2 days and reduces complications.

Antiviral Medications

Drug	Class	Typical Adult Dose	Key Points
Oseltamivir (Tamiflu)	Neuraminidase inhibitor	75 mg PO twice daily for 5 days	Effective against A & B; approved for treatment & prophylaxis; nausea common.
Zanamivir (Relenza)	Neuraminidase inhibitor	10 mg inhaled twice daily for 5 days	Not for patients with respiratory disease (asthma/COPD); requires inhaler.
Baloxavir marboxil (Xofluza)	Cap‑dependent endonuclease inhibitor	Single oral dose (weight‑based: 40 mg < 80 kg; 80 mg ≥ 80 kg)	One‑dose regimen; effective against resistant strains; limited data in pregnancy.
Peramivir (Rapivab)	Neuraminidase inhibitor	600 mg IV single dose (adults)	Used for hospitalized patients who cannot take oral meds.

All antivirals are most beneficial when started within 48 hours of symptom onset, but may be considered later for hospitalized or high‑risk patients.

Supportive Care

• Rest and hydration – adequate fluid intake prevents dehydration.
• Acetaminophen or ibuprofen for fever and myalgias (avoid aspirin in children/teens with viral illness – risk of Reye syndrome).
• Humidified air, saline nasal sprays, and throat lozenges for symptomatic relief.
• Oxygen supplementation for hypoxemia.
• Mechanical ventilation for respiratory failure (ICU setting).

Lifestyle Adjustments

While on medication, avoid alcohol (it can worsen liver toxicity from acetaminophen) and refrain from intense physical activity until fever resolves.

Living with Seasonal Flu (Influenza)

Even with the best medical care, flu patients need practical strategies to manage daily life and prevent spread.

• Isolation – Stay home at least 24 hours after fever subsides without fever‑reducing meds.
• Hydration – Aim for 2‑3 L of fluids daily (water, broth, electrolyte solutions).
• Nutrition – Light, easy‑to‑digest foods (e.g., oatmeal, bananas, toast) support recovery.
• Sleep – 7‑9 hours of uninterrupted sleep promotes immune function.
• Hand hygiene – Wash hands with soap for ≥ 20 seconds; use alcohol‑based sanitizer when unavailable.
• Monitor symptoms – Keep a symptom diary; watch for any worsening that would require medical review.

Prevention

The cornerstone of flu prevention is vaccination, complemented by behavioral measures.

Vaccination

• Who should get the annual flu vaccine? Everyone ≥ 6 months of age, with rare contraindications (e.g., severe egg allergy for certain formulations).
• Vaccine types – Inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV), and live attenuated influenza vaccine (LAIV) for non‑pregnant, non‑immunocompromised individuals 2‑49 years.
• Effectiveness varies yearly (10‑60%) but consistently reduces hospitalization and death, especially in high‑risk groups (CDC 2023 data).

Non‑pharmaceutical Interventions

• Hand washing and use of alcohol‑based hand rubs.
• Avoid close contact with sick individuals; keep a distance of ≥ 1 meter when possible.
• Cover coughs and sneezes with a tissue or elbow; discard tissue immediately.
• Regularly clean high‑touch surfaces (doorknobs, phones) with EPA‑approved disinfectants.
• Stay home when ill – adherence to sick‑leave policies reduces community spread.

Complications

Complications arise when the virus damages lung tissue or triggers an exaggerated immune response.

• Pneumonia – Primary viral or secondary bacterial (Streptococcus pneumoniae, Staphylococcus aureus).
• Exacerbation of chronic diseases – Asthma, COPD, heart failure, and diabetes may worsen.
• Myocarditis and pericarditis – Inflammation of heart muscle or sac.
• Encephalitis, seizures, or Guillain‑Barré syndrome – Rare neurologic sequelae.
• Acute metabolic decompensation – Particularly in children with underlying metabolic disorders.
• Sepsis and multi‑organ failure – Predominantly in older adults and immunocompromised patients.

According to the World Health Organization (WHO), up to 30% of hospitalized flu patients develop pneumonia, and mortality is highest in those > 65 years.

When to Seek Emergency Care

---

Sources: CDC, WHO, Mayo Clinic, National Institutes of Health (NIH), Cleveland Clinic, peer‑reviewed articles in The Lancet Infectious Diseases and JAMA (2022‑2024). All information is for educational purposes and does not replace professional medical advice.

```